ReviewOncotarget2012

Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.

Alberto M Martelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.